BALTIMORE DAVID
SEC insider (Form 3/4/5 filer). CIK 0001185858. Director at Regulus Therapeutics Inc. (RGLS). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2025. Located in SAN DIEGO, CA.
Companies BALTIMORE DAVID has filed insider reports for
- Regulus Therapeutics Inc. (RGLS): Director
BALTIMORE DAVID
CIK: 0001185858
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Regulus Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 25, 2025RGLS
Regulus Therapeutics Inc.
Tender OfferDirect27.4K shares- - Jun 25, 2025RGLS
Regulus Therapeutics Inc.
DispositionDirect57.3K shares- - Jun 25, 2025RGLS
Regulus Therapeutics Inc.
Tender OfferIndirect5.2K shares- - Jun 25, 2025RGLS
Regulus Therapeutics Inc.
DispositionIndirect57.3K shares- - Apr 30, 2025RGLS
Regulus Therapeutics Inc.
AwardDirect62.5K shares- - Apr 30, 2025RGLS
Regulus Therapeutics Inc.
AwardIndirect62.5K shares- - Jan 30, 2025RGLS
Regulus Therapeutics Inc.
PurchaseDirect19.6K shares at avg. $1.06$21K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | Tender Offer | 27,377 | - | - | Direct |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | Disposition | 57,292 | - | - | Direct |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | Tender Offer | 5,208 | - | - | Indirect |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | Disposition | 57,292 | - | - | Indirect |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | Award | 62,500 | - | - | Direct |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | Award | 62,500 | - | - | Indirect |
| Jan 30, 2025 | RGLS Regulus Therapeutics Inc. | Purchase | 19,610 | $1.06 | $20,787 | Direct |
1-7 of 7 transactions